This prospective randomized double-blind clinical trial will be conducted at Ain-Shams
University Maternity Hospital, Cairo, Egypt. Patients eligible for elective lower segment
cesarean section will be randomized to 2 groups. Group 1: will receive 400 ug misoprostol
following + 10 IU oxytocin intravenous slowly after cord clamping. Group 2: will receive 100
ug carbetocin intravenous after cord clamping.